‘More monopoly doesn’t mean more innovation’: Lawmakers move to scrap biotech patent perk

EU PERSPECTIVES - Two European Parliament committees have moved to delete the Biotech Act's most contested measure: a proposed 12-month extension of market protection for biotech medicines. Read more

"European biotechnology leadership will not be based on ad infinitum extensions to intellectual property," says ENVI rapporteur Nicolás González Casares. / Photo: Unsplash